Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

8.61
+0.17002.01%
Post-market: 8.60-0.0100-0.12%19:30 EDT
Volume:2.21M
Turnover:19.00M
Market Cap:420.91M
PE:-2.68
High:8.75
Open:8.45
Low:8.40
Close:8.44
52wk High:14.53
52wk Low:2.29
Shares:48.89M
Float Shares:18.98M
Volume Ratio:5.44
T/O Rate:11.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2084
EPS(LYR):-3.4309
ROE:-36.58%
ROA:-22.34%
PB:1.21
PE(LYR):-2.51

Loading ...

Sep 11, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 11, 2026

Major Issues Report

Form 8-K - Current report
Sep 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 10, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 22, 2026

Major Issues Report

Form 8-K - Current report
May 19, 2026

Major Issues Report

Form 8-K - Current report
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 08, 2026

Major Issues Report

Form 8-K - Current report
May 08, 2026

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 08, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]